INmune Bio says Phase 2 XPro trial shows significant Week 24 MRI myelin benefit in early Alzheimer’s patients

INmune Bio, Inc.

INmune Bio, Inc.

INMB

0.00
  • INmune Bio disclosed new Phase 2 MRI data for XPro in early Alzheimer’s disease ahead of an AAIC 2026 presentation.
  • White matter myelin integrity showed a statistically significant treatment difference at Week 24 in the modified intent-to-treat population (p<0.01).
  • Advanced imaging also indicated early cortical microstructure changes at Week 24, supporting biologic activity of selective soluble TNF inhibition.
  • Larger effects were reported in patients selected using the company’s biomarker enrichment strategy.
  • Expanded analyses from the MINDFuL study are scheduled for July 12 at AAIC 2026 in London.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. INmune Bio Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607090700PRIMZONEFULLFEED9759275) on July 09, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.